Vitamin E v placebo for adults at high risk for cardiovascular events§
| Outcomes at mean 4.5 years | Vitamin E | Placebo | RRI (95% CI) | NNH |
|---|---|---|---|---|
| §Abbreviations defined in glossary; RRI, NNH, and CI calculated from data in article. | ||||
| Myocardial infarction, stroke, or cardiovascular mortality | 16% | 15% | 5% (−4 to 15) | Not significant |
| Cardiovascular mortality | 7.1% | 6.9% | 5% (−10 to 21) | Not significant |
| Myocardial infarction | 11.2% | 11.0% | 2% (−9 to 14) | Not significant |
| Stroke | 4.4% | 3.8% | 17% (−4 to 42) | Not significant |
| All cause mortality | 11% | 11% | 0% (−11 to 12) | Not significant |